GPC3 and cancer: We then conducted clinical trials of GPC3 peptide vaccines for hepatocellular carcinoma, ovarian clear cell carcinoma, and pediatric cancer [12,13,14,15,16,17,18,19], where we demonstrated multiple cases of partial response in advanced cancer and recurrence prevention.